Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 512540, 7 pages
http://dx.doi.org/10.1155/2014/512540
Research Article

Evaluation of Diagnostic Value in Using a Panel of Multiple Tumor-Associated Antigens for Immunodiagnosis of Cancer

Center for Tumor Biotherapy, The First Affiliated Hospital and College of Public Health and Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, Henan 450052, China

Received 6 February 2014; Accepted 10 March 2014; Published 13 April 2014

Academic Editor: Bin Zhang

Copyright © 2014 Peng Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. M. Tan and J. Zhang, “Autoantibodies to tumor-associated antigens: reporters from the immune system,” Immunological Reviews, vol. 222, no. 1, pp. 328–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-Y. Zhang and E. M. Tan, “Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors,” Expert Review of Molecular Diagnostics, vol. 10, no. 3, pp. 321–328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Soussi, “p53 Antibodies in the sera of patients with various types of cancer: a review,” Cancer Research, vol. 60, no. 7, pp. 1777–1788, 2000. View at Google Scholar · View at Scopus
  4. K. Looi, R. Megliorino, F.-D. Shi, X.-X. Peng, Y. Chen, and J.-Y. Zhang, “Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies,” Oncology Reports, vol. 16, no. 5, pp. 1105–1110, 2006. View at Google Scholar · View at Scopus
  5. J.-Y. Zhang, E. K. L. Chan, X.-X. Peng, and E. M. Tan, “A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma,” The Journal of Experimental Medicine, vol. 189, no. 7, pp. 1101–1110, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Kao, J. A. Marto, T. K. Hoffmann et al., “Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells,” The Journal of Experimental Medicine, vol. 194, no. 9, pp. 1313–1323, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Ersvaer, J.-Y. Zhang, E. McCormack et al., “Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients,” European Journal of Haematology, vol. 79, no. 3, pp. 210–225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. S. Anderson and J. LaBaer, “The sentinel within: exploiting the immune system for cancer biomarkers,” Journal of Proteome Research, vol. 4, no. 4, pp. 1123–1133, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Himoto, S. Kuriyama, J.-Y. Zhang, E. K. L. Chan, M. Nishioka, and E. M. Tan, “Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma,” International Journal of Oncology, vol. 26, no. 2, pp. 311–317, 2005. View at Google Scholar · View at Scopus
  10. J. Zhang, K. Wang, J. Zhang, S. S. Liu, L. Dai, and J.-Y. Zhang, “Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma,” Journal of Proteome Research, vol. 10, no. 6, pp. 2863–2872, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J.-Y. Zhang, “Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma,” Autoimmunity Reviews, vol. 6, no. 3, pp. 143–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Li, K. Wang, L. Dai, P. Wang, X.-X. Peng, and J.-Y. Zhang, “Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer,” Molecular Medicine Reports, vol. 1, no. 4, pp. 589–594, 2008. View at Google Scholar · View at Scopus
  13. J.-Y. Zhang, R. Megliorino, X.-X. Peng, E. M. Tan, Y. Chen, and E. K. L. Chan, “Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma,” Journal of Hepatology, vol. 46, no. 1, pp. 107–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Liu, P. Wang, Z. Li et al., “Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer,” Scandinavian Journal of Immunology, vol. 69, no. 1, pp. 57–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Ye, C. Sun, P. Ren et al., “Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer,” Oncology Letters, vol. 5, no. 2, pp. 663–668, 2013. View at Google Scholar
  16. J.-Y. Zhang, C. A. Casiano, X.-X. Peng, J. A. Koziol, E. K. L. Chan, and E. M. Tan, “Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 2, pp. 136–143, 2003. View at Google Scholar · View at Scopus
  17. W. Q. Chen, “Assessing the validity and reliability of screening test,” in Epidemiology, L. M. Li, Ed., pp. 289–292, The People’ Health, Beijing, China, 2004. View at Google Scholar
  18. W. H. Liu, Z. Li, P. Wang et al., “Evaluation of diagnostic value on lung cancer using a panel of multiple tumor-associated antigens,” Chinese Journal of Health Laboratory Technology, vol. 16, pp. 1412–1414, 2006. View at Google Scholar
  19. X. Wang, J. Yu, A. Sreekumar et al., “Autoantibody signatures in prostate cancer,” The New England Journal of Medicine, vol. 353, pp. 1224–1235, 2005. View at Publisher · View at Google Scholar
  20. R. Lubin, G. Zalcman, L. Bouchet et al., “Serum p53 antibodies as early markers of lung cancer,” Nature Medicine, vol. 1, no. 7, pp. 701–702, 1995. View at Google Scholar · View at Scopus
  21. G. Zalcman, B. Schlichtholz, J. Trédaniel et al., “Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment,” Clinical Cancer Research, vol. 4, no. 6, pp. 1359–1366, 1998. View at Google Scholar · View at Scopus